REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kiraly Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Kiraly Pharma Gyogyszerkiskereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Kiraly Pharma Kft. is based in Hungary. The head office is in Eger. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on May 18, 2018. It currently has a total number of 11 (2024) employees. From the latest financial highlights, Kiraly Pharma Kft. reported a net sales revenue increase of 19.25% in 2023. Its total assets decreased by 10.48% over the same period. In 2023, Kiraly Pharma Kft.’s net profit margin decreased by 2.2%.

Headquarters
Lajer Dezso utca 5.
Eger; Heves; Postal Code: 3300

Contact Details: Purchase the Kiraly Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Kiraly Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Kiraly Pharma Kft. report to view the information.
Registered Capital:
Purchase the Kiraly Pharma Kft. report to view the information.
Incorporation Date:
May 18, 2018
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Kiraly Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
19.25%▲
Total operating revenue
19.14%▲
Operating profit (EBIT)
-16.01%▼
EBITDA
-11.14%▼
Net Profit (Loss) for the Period
-17.09%▼
Total assets
-10.48%▼
Total equity
-2.13%▼
Operating Profit Margin (ROS)
-2.34%▼
Net Profit Margin
-2.2%▼
Return on Equity (ROE)
-9.61%▼
Quick Ratio
0.15%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo